Skip to main content
TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
0.2200
+0.0280 (14.58%)
At close: Apr 25, 2025, 4:00 PM
0.2250
+0.0050 (2.27%)
Pre-market: Apr 28, 2025, 6:45 AM EDT

TNF Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-23.36-4-15.2-29.89-9.49
Upgrade
Depreciation & Amortization
----0.02
Upgrade
Other Amortization
---0.611.19
Upgrade
Loss (Gain) From Sale of Investments
-0-000-
Upgrade
Stock-Based Compensation
1.663.050.70.090.86
Upgrade
Other Operating Activities
13.64-12.84-14.852.19
Upgrade
Change in Accounts Payable
-0.811.041.69-4.270.56
Upgrade
Change in Other Net Operating Assets
-0.1-0.230.54-0.910.02
Upgrade
Operating Cash Flow
-8.98-12.98-12.27-19.52-4.66
Upgrade
Cash Acquisitions
---1.38-
Upgrade
Investment in Securities
-6.11.856.9118.47-
Upgrade
Investing Cash Flow
-6.11.856.9119.85-
Upgrade
Short-Term Debt Issued
---1.831.27
Upgrade
Long-Term Debt Issued
---0.121.43
Upgrade
Total Debt Issued
---1.952.7
Upgrade
Long-Term Debt Repaid
----3.06-
Upgrade
Net Debt Issued (Repaid)
----1.122.7
Upgrade
Issuance of Common Stock
--5.551.191.98
Upgrade
Preferred Dividends Paid
-1.36-1.45---
Upgrade
Dividends Paid
-1.36-1.45---
Upgrade
Other Financing Activities
--0.08---
Upgrade
Financing Cash Flow
12.5713.075.550.074.68
Upgrade
Net Cash Flow
-2.511.930.190.410.01
Upgrade
Cash Interest Paid
--0.010.27-
Upgrade
Levered Free Cash Flow
-2-5.27-6.6-4.28-0.93
Upgrade
Unlevered Free Cash Flow
-2-5.27-6.6-4.51-1.37
Upgrade
Change in Net Working Capital
-1.75-1.91-2.261.92-0.93
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q